USFDA conducts inspection at Cipla#39;s Indore facility
newsdepo.com
«The United States Food and Drug Administration (USFDA) conducted a routine current Good Manufacturing Practices (cGMP) audit at its Indore formulations facility from April 2, 2018 till April 13, 2018,» Cipla said in a BSE filing.USFDA conducts inspection at Cipla#39;s Indore facility
«The United States Food and Drug Administration (USFDA) conducted a routine current Good Manufacturing Practices (cGMP) audit at its Indore formulations facility from April 2, 2018 till April 13, 2018,» Cipla said in a BSE filing. Read more